DSM Venturing

Founded in 2001, DSM Venturing is the corporate venture capital arm of Royal DSM, based in Heerlen, Netherlands. The firm invests in companies developing innovative products and services in sectors of life sciences (animal and human health & nutrition) and biomedical.

Rob Beudeker

Investment Director

Philip Hul

Finance Director

Luda Kopeikina

Investment Director

Akshat Kshetrapal

Investment Director

Greg McParland

Investment Director

Arpesh Mehta

Investment Director

Philip Mertens

Associate

Erik Rutten

Senior Investment Manager

Pieter Wolters

Managing Director

76 past transactions

VitaminLab

Series A in 2023
VitaminLab takes your health history, our nutrient testing or health data, and uses our matching algorithm to create an all-in-one personalized supplement that impacts your health. The company, run by a team of pharmacists and health care professionals, was founded to change the status quo of the supplement industry.

Rootine

Series A in 2022
Rootine is a precision nutrition platform that utilizes evidence-based technology to analyze biometric and lifestyle data, providing personalized nutrition recommendations. The company's approach focuses on connecting various health data points to improve individual health outcomes. By leveraging patient data, Rootine crafts tailored vitamin regimens that adapt to the unique biological needs of each person. Its artificial intelligence system continuously refines these recommendations and nutrient formulas as users' bodies change, ensuring that individuals receive optimized support for their health goals. This personalized approach aims to empower clients to make informed health decisions based on real-time data and ongoing progress tracking.

Phytolon

Series A in 2022
Phytolon Ltd, located in Misgav, Israel, specializes in the development of technology for producing natural food colorants. Founded in 2000, the company utilizes baker's yeast cells as bio-factories to create these colorants through a fermentation process. Phytolon's innovative approach aims to provide sustainable and natural alternatives for the food and beverage industry, addressing the growing demand for clean-label products.

Chinova Bioworks

Series A in 2022
Chinova Bioworks Inc. develops personalized natural antimicrobials for the beverage industry. Its natural antimicrobials protect fresh juices from spoilage and enhance the shelf life of these products. The company was founded in 2016 and is based in Fredericton, Canada.

inne

Series A in 2022
Inne is a Berlin-based biotech startup focused on developing a hormone-based mini lab designed for women to monitor their fertility. The company aims to provide a convenient and accurate method for natural contraception, enabling women to better understand their bodies and make informed choices regarding their reproductive health. Inne's innovative device analyzes fertility hormones in saliva, offering insights into ovulation, menstrual cycles, and hormone levels. By utilizing biochemistry combined with a user-friendly app, Inne empowers women to identify their fertility phases based on hormonal readings, fostering a greater awareness of their overall female health.

OK Capsule

Seed Round in 2022
OK Capsule is a provider of an online supply chain and product development software for the life science industry. Its enterprise supplement personalization platform provides custom-branded rolls of supplement packets that are more cost-effective than bottles and sustainable for the planet and are made using supplements that are ethnically sourced, fair trade, organic, kosher or halal, non-GMO and dairy, glyphosate, and soy-free that enable businesses to scale the delivery of individualized, premium-grade supplement packets to their customers that is safe for the environment and sustainable.

ATRO Medical

Venture Round in 2021
ATRO Medical B.V., based in Nijmegen, the Netherlands, specializes in the development of an anatomically shaped polymer-based meniscus implant known as the Trammpolin. This innovative implant is designed to restore the protective function of the meniscus by acting as a spacer in the joint. ATRO Medical emerged as a spin-out from DSM and Radboudumc, leveraging expertise gained from a collaborative initiative that began in 2010, which included universities, private companies, and support from the Dutch government. The company combines clinical, biomechanical, and polymer knowledge to advance the Trammpolin design and its prototype development.

OK Capsule

Seed Round in 2021
OK Capsule is a provider of an online supply chain and product development software for the life science industry. Its enterprise supplement personalization platform provides custom-branded rolls of supplement packets that are more cost-effective than bottles and sustainable for the planet and are made using supplements that are ethnically sourced, fair trade, organic, kosher or halal, non-GMO and dairy, glyphosate, and soy-free that enable businesses to scale the delivery of individualized, premium-grade supplement packets to their customers that is safe for the environment and sustainable.

Rootine

Seed Round in 2021
Rootine is a precision nutrition platform that utilizes evidence-based technology to analyze biometric and lifestyle data, providing personalized nutrition recommendations. The company's approach focuses on connecting various health data points to improve individual health outcomes. By leveraging patient data, Rootine crafts tailored vitamin regimens that adapt to the unique biological needs of each person. Its artificial intelligence system continuously refines these recommendations and nutrient formulas as users' bodies change, ensuring that individuals receive optimized support for their health goals. This personalized approach aims to empower clients to make informed health decisions based on real-time data and ongoing progress tracking.

Prenexus Health

Series B in 2021
Prenexus Health is a prebiotic ingredient manufacturer focused on digestive health and wellness through the research, development and production of branded prebiotic ingredients for vitamin, dietary supplement, food and beverage products. As a science-based company, Prenexus Health is an innovative global leader in prebiotics supported by scientific and clinical research with an emphasis in digestive and microbiome health.

Leading Edge Equipment Technologies

Convertible Note in 2021
Leading Edge Equipment Technologies, based in Gloucester, Massachusetts, specializes in the development and manufacturing of kerfless, single crystal silicon wafers designed for use in solar panels. Founded in 2016, the company focuses on creating wafers that enhance efficiency and reduce costs while seamlessly integrating into existing module manufacturing processes without necessitating any modifications.

Brains Bioceutical

Series A in 2021
Brains Bioceutical Corp. engages in the production of naturally-sourced active pharmaceutical ingredients (API) for the pharmaceutical and nutraceutical industries. The company offers CBD oil, capsules, balm, and spray. It serves pharmaceutical; health and wellness; skin and beauty; and veterinary sectors. The company is based in Vancouver, Canada.

Meatable

Series A in 2021
Meatable B.V. is a food production company based in the Netherlands that specializes in the development of lab-grown meat and meat products derived from cows, chickens, and pigs. Founded in 2018, the company focuses on producing single-cell based hamburgers and aims to address concerns related to climate change, animal welfare, and food security. By utilizing innovative techniques, Meatable seeks to provide a sustainable alternative to traditional meat production, allowing consumers to enjoy real meat without compromising ethical or environmental standards. Through its efforts, the company aspires to satisfy the global demand for meat while promoting a more responsible and guilt-free approach to food consumption.

Deep Branch Biotechnology

Series A in 2021
Deep Branch Biotechnology Ltd., founded in 2018 and based in Nottingham, United Kingdom, with additional offices in the Netherlands, specializes in carbon recycling services. The company has developed scalable technology that converts carbon dioxide from industrial waste gas into clean, nutritious, and sustainable single-cell protein. This innovative process not only helps to reduce the carbon footprint of polluting industries but also offers sustainable alternatives to traditional feed sources such as soy and fishmeal. By transforming emissions into valuable protein, Deep Branch Biotechnology aims to contribute to a more sustainable future in the feed industry.

Novum Medical

Venture Round in 2021
Novum Medical is a privately-held medical device company based in Woburn, Massachusetts, specializing in innovative bone graft substitute products designed for spine and foot and ankle surgeries. Utilizing its proprietary Cross-Linked Microstructure (CLM) technology, Novum Medical develops biocompatible materials that exhibit enhanced mechanical and biological properties, facilitating effective surgical solutions. The company's product pipeline includes a variety of bone graft substitutes such as beta and epsilon wedges for mid-foot osteotomies, as well as devices for the surgical repair of hammertoe deformity and interbody devices for spinal fusion. Established in 2009, Novum Medical is committed to advancing musculoskeletal clinical practice through rapid and cost-effective component fabrication methods.
Additive Manufacturing Technologies specializes in automated post-processing solutions for 3D printed parts, targeting high-volume production across various industrial sectors. The company integrates advancements in material science, chemistry, hardware engineering, robotics, and machine learning to enhance the quality and reliability of 3D printed components. By focusing on the post-processing phase, AMT helps companies optimize their additive manufacturing facilities, improving efficiency and reducing lead times and manufacturing costs. Their technology supports a seamless digital workflow, enabling clients to meet market-ready specifications effectively and scale up production capabilities.

Frontier Nutrition

Series B in 2021
Frontier Nutrition, Inc. is a company that develops and manufactures nutritious food products aimed at addressing the dietary needs of families in low-income communities globally. Established in 2016 and based in Dover, Delaware, Frontier Nutrition focuses on creating innovative and appealing packaged food items that cater to the specific nutritional requirements of these communities. The company's offerings are grounded in advanced research in pediatric nutrition and behavioral marketing, ensuring that the recipes are tailored to traditional diets while optimizing for taste, nutrition, and affordability. Through its strategic initiatives, Frontier Nutrition strives to make a meaningful impact on the health and well-being of underserved populations.
Leading Edge Equipment Technologies, based in Gloucester, Massachusetts, specializes in the development and manufacturing of kerfless, single crystal silicon wafers designed for use in solar panels. Founded in 2016, the company focuses on creating wafers that enhance efficiency and reduce costs while seamlessly integrating into existing module manufacturing processes without necessitating any modifications.

NutriLeads

Series B in 2020
NutriLeads is an innovative startup that develops nutritional ingredients with demonstrated health effects. NutriLeads aims to catalyze nutritional health innovation in the food industry by partnering with relevant companies to identify promising lead ingredients, develop sustainable and commercially viable production processes, and initiate scientific & clinical programs to substantiate the health effects of these ingredients. Together we will bring the benefits of the proprietary ingredients to patients and consumers.

Phynova Group

Venture Round in 2020
Phynova is a British life science company that develops and commercialises natural healthcare products derived from active compounds found in plants. Founded in 2002, Phynova is an innovative life science company based in Oxford, UK with a subsidiary research company located in Beijing, China. Phynova develops and commercialises natural healthcare products derived from active compounds found in plants. Phynova develops products for use in global healthcare and FMCG markets. It identifies active ingredients from plants with a rich history of use in traditional medicine, especially in China, and develops solutions for global health concerns.

Panaceutics Inc.

Series A in 2020
Panaceutics Inc. engages in formulation, manufacturing, and distribution of medicines. The company offers technology to transform multiple pills into a single packet of easy-to-swallow fruit puree for macro nutrient needs. It serves to healthcare systems, integrated delivery partners, pharmaceutical companies, and nutritional product manufacturers. The company was founded in 2013 and is based in Research Triangle Park, North Carolina.

Inkbit

Venture Round in 2019
Inkbit Corporation is a Medford, Massachusetts-based company that specializes in the research, development, and manufacturing of 3D printers. Founded in 2017, Inkbit focuses on creating a next-generation additive manufacturing platform that integrates machine learning and artificial intelligence with material jetting and machine vision. The company leverages the expertise of MIT-trained scientists and engineers in industrial systems, design software, and material science to advance opportunities in mass-market additive manufacturing. Through its innovative approach, Inkbit aims to enhance the capabilities and applications of 3D printing technology.

Voxel8

Series B in 2019
Voxel8 Inc. is a company focused on advancing 3D printing technology by integrating electronic functionalities into traditional 3D printed structures. Established in 2013 and located in Somerville, Massachusetts, Voxel8 designs and manufactures desktop 3D printers capable of printing thermoplastics and UV resins. The company specializes in innovative materials that enable the embedding of conductors, wires, and batteries within standard 3D printing matrices, based on research from Harvard University. Additionally, Voxel8 offers Project Wire, a cloud-based software tool that assists users in designing 3D printable electronic devices that can be efficiently produced using their printers.

Voxel8

Series B in 2019
Voxel8 Inc. is a company focused on advancing 3D printing technology by integrating electronic functionalities into traditional 3D printed structures. Established in 2013 and located in Somerville, Massachusetts, Voxel8 designs and manufactures desktop 3D printers capable of printing thermoplastics and UV resins. The company specializes in innovative materials that enable the embedding of conductors, wires, and batteries within standard 3D printing matrices, based on research from Harvard University. Additionally, Voxel8 offers Project Wire, a cloud-based software tool that assists users in designing 3D printable electronic devices that can be efficiently produced using their printers.
Additive Manufacturing Technologies specializes in automated post-processing solutions for 3D printed parts, targeting high-volume production across various industrial sectors. The company integrates advancements in material science, chemistry, hardware engineering, robotics, and machine learning to enhance the quality and reliability of 3D printed components. By focusing on the post-processing phase, AMT helps companies optimize their additive manufacturing facilities, improving efficiency and reducing lead times and manufacturing costs. Their technology supports a seamless digital workflow, enabling clients to meet market-ready specifications effectively and scale up production capabilities.

Chinova Bioworks

Seed Round in 2019
Chinova Bioworks Inc. develops personalized natural antimicrobials for the beverage industry. Its natural antimicrobials protect fresh juices from spoilage and enhance the shelf life of these products. The company was founded in 2016 and is based in Fredericton, Canada.

ZeaVision

Venture Round in 2019
ZeaVision develops products for EyeCare Professionals and patients. ZeaVision's mission is to develop and market science-based supplements and vision care products to support healthy vision and prevent vision loss in the lives of many.

Panaceutics Inc.

Venture Round in 2019
Panaceutics Inc. engages in formulation, manufacturing, and distribution of medicines. The company offers technology to transform multiple pills into a single packet of easy-to-swallow fruit puree for macro nutrient needs. It serves to healthcare systems, integrated delivery partners, pharmaceutical companies, and nutritional product manufacturers. The company was founded in 2013 and is based in Research Triangle Park, North Carolina.

Hyalex Orthopaedics

Series A in 2019
Hyalex Orthopaedics, Inc. is a medical device company based in Lexington, Massachusetts, focused on developing innovative products that utilize HYALEX technology, a synthetic polymer engineered to mimic cartilage. Founded in 2016, the company specializes in creating a biomimetic material that can effectively simulate healthy cartilage to treat diseased or damaged joints. The unique properties of HYALEX allow it to maintain low friction and wear, even under the significant loads typically experienced in human joints. This capability enables surgeons to replace arthritic cartilage while preserving healthy bone. Although Hyalex Orthopaedics is advancing its product development, its offerings have not yet received approval for use in humans from any regulatory agency.

Adaptive3D

Series A in 2019
Adaptive3D is a leading supplier of premium additive manufacturing polymer resins focused on enabling high-volume production through optimized materials. The company specializes in a range of products, including rubber-like 3D printable materials, damping materials, and low-cure stress photopolymers. By leveraging pioneering technologies, Adaptive3D partners with global leaders to provide solutions for functional end-use products and prototypes, allowing clients to achieve differentiated products and enhanced part performance. Their advanced materials are designed to support precise internal geometries and facilitate the economical customization of parts, making them a key player in the additive manufacturing industry.

Raycatch

Series B in 2018
RayCatch Ltd. develops an automated SaaS system which analyzes the grid's data and provides instructions for optimizing the maintenance and efficiency of the grid. The company is based in Israel.

Miach Orthopaedics

Series A in 2018
Miach Orthopaedics is a medical device company that develops bio-engineered surgical implants to facilitate new tissue growth. The company's product is the Bridge-Enhanced ACL Repair technology as a viable alternative to conventional ACL reconstruction for patients who have withstand an anterior cruciate ligament injury. Miach Orthopaedics was founded on 2016 and is headquartered in Westborough, Massachusetts.

Novum Medical

Series C in 2018
Novum Medical is a privately-held medical device company based in Woburn, Massachusetts, specializing in innovative bone graft substitute products designed for spine and foot and ankle surgeries. Utilizing its proprietary Cross-Linked Microstructure (CLM) technology, Novum Medical develops biocompatible materials that exhibit enhanced mechanical and biological properties, facilitating effective surgical solutions. The company's product pipeline includes a variety of bone graft substitutes such as beta and epsilon wedges for mid-foot osteotomies, as well as devices for the surgical repair of hammertoe deformity and interbody devices for spinal fusion. Established in 2009, Novum Medical is committed to advancing musculoskeletal clinical practice through rapid and cost-effective component fabrication methods.

Chinova Bioworks

Seed Round in 2018
Chinova Bioworks Inc. develops personalized natural antimicrobials for the beverage industry. Its natural antimicrobials protect fresh juices from spoilage and enhance the shelf life of these products. The company was founded in 2016 and is based in Fredericton, Canada.

Chromatic 3D Materials

Series A in 2018
For the first time ever, manufacturers will have the materials required to build durable, functional designs. Chromatic 3D Materials is inventing the next generation of 3D printing materials with the durability to meet the requirements for finished manufactured goods. Today, our reality includes infinite possibilities for novel product designs, made possible by our customizable property range. The scope of destinations for these technologies is vast.

Tespo

Series A in 2018
At Tespo, they create innovative products for customers to help improve their quality of life and deliver an experience that exceeds their expectations. Tespo’s system provides all the storage, convenience and daily use benefits of a vitamin pill without the drawbacks - no fillers, binders, additives or unnecessary ingredients. By leveraging a disc/dispenser design - Tespo provides an individual liquid vitamin serving everyday delivered straight to your door each month.
Leading Edge Equipment Technologies, based in Gloucester, Massachusetts, specializes in the development and manufacturing of kerfless, single crystal silicon wafers designed for use in solar panels. Founded in 2016, the company focuses on creating wafers that enhance efficiency and reduce costs while seamlessly integrating into existing module manufacturing processes without necessitating any modifications.

ATRO Medical

Series A in 2017
ATRO Medical B.V., based in Nijmegen, the Netherlands, specializes in the development of an anatomically shaped polymer-based meniscus implant known as the Trammpolin. This innovative implant is designed to restore the protective function of the meniscus by acting as a spacer in the joint. ATRO Medical emerged as a spin-out from DSM and Radboudumc, leveraging expertise gained from a collaborative initiative that began in 2010, which included universities, private companies, and support from the Dutch government. The company combines clinical, biomechanical, and polymer knowledge to advance the Trammpolin design and its prototype development.

NutriLeads

Series A in 2017
NutriLeads is an innovative startup that develops nutritional ingredients with demonstrated health effects. NutriLeads aims to catalyze nutritional health innovation in the food industry by partnering with relevant companies to identify promising lead ingredients, develop sustainable and commercially viable production processes, and initiate scientific & clinical programs to substantiate the health effects of these ingredients. Together we will bring the benefits of the proprietary ingredients to patients and consumers.

QD Solar Inc.

Series A in 2017
The solar photovoltaic market is one of the fastest growing energy markets in the world. That growth comes amidst the race to the bottom on cell and module pricing driven by fierce supply side market competition. PV manufacturers can no longer count on economies of scale and incremental process improvements to attain profit in the face of competitive pricing pressures. Manufacturers need to differentiate their product by delivering better performance for the same or lower cost. QD Solar, a University of Toronto spinoff company, will provide this differentiation.

WattGlass

Series A in 2017
WattGlass LLC, founded in 2014 and based in Fayetteville, Arkansas, specializes in developing innovative water-based anti-reflective coatings designed to eliminate reflection, glare, and fogging on glass and other transparent materials. The company's proprietary nanoparticle technology, initially developed during research at the University of Arkansas, offers a safe and environmentally friendly alternative to hazardous materials typically used in coatings. WattGlass's solutions cater to various industries, including automotive, consumer goods, architectural glass, and solar photovoltaic applications. The company has secured exclusive licensing for its technology and has filed multiple patents to further enhance its product offerings.

Essential Medical

Series B in 2016
Essential Medical, Inc. is a medical device company based in Malvern, Pennsylvania, that specializes in developing femoral artery vascular closure devices. Founded in 2010, the company focuses on sealing femoral punctures that occur after diagnostic and interventional cardiac catheterization procedures. Essential Medical has created two primary closure devices, including MANTA, which is specifically designed to address large bore punctures ranging from 10 to 24 French. These devices are particularly relevant for procedures such as transcatheter aortic valve replacement (TAVR), abdominal aortic aneurysm repair (AAA/PVAR), and balloon aortic valvuloplasty (BAV). The innovations from Essential Medical aim to fulfill a significant need in interventional cardiology by providing efficient closure solutions that minimize complications for patients. Since October 2018, the company operates as a subsidiary of Teleflex Incorporated.

Blue Prairie

Series A in 2016
Blue Prairie Brands LLC is a manufacturer based in Charlottesville, Virginia, specializing in inulin, a prebiotic ingredient that enhances the fiber and nutritional content of food, beverages, and supplements. The company offers innovative, whole-food products that are gluten-free and non-GMO, supporting digestive health in conjunction with probiotics. In addition to its flagship inulin product, Blue Prairie Brands provides chicory and agave. The company's proprietary production methods not only focus on health benefits but also offer farmers a profitable crop rotation option, utilizing their existing equipment and expertise.

Arecor

Venture Round in 2016
Arecor is a leader in developing superior biopharmaceuticals through the application of its innovative formulation technology platform. Arecor is leveraging this platform to develop a portfolio of proprietary products enabling improved treatments for diabetes care via the innovative reformulation of approved proteins and peptides. In addition to its internal product portfolio, Arecor partners with leading pharmaceutical and biotech companies to deliver superior reformulations of their proprietary products, which would otherwise not be possible using conventional formulation science.

NOMADD

Series A in 2016
NOMADD specializes in innovative cleaning solutions for solar panels in desert environments. The company has developed the NO-water Mechanical Automated Dusting Device, a system designed to address the unique challenges posed by dust accumulation in arid climates. This automated device allows for effective cleaning of solar panels without the use of water, ensuring that the panels remain undamaged while maintaining their efficiency. NOMADD's technology originated from research conducted at the King Abdullah University for Science and Technology, located near Jeddah, Saudi Arabia. The company's focus on waterless cleaning solutions positions it as a key player in the solar energy sector, particularly in regions where traditional cleaning methods may be impractical.

NutriLeads

Seed Round in 2015
NutriLeads is an innovative startup that develops nutritional ingredients with demonstrated health effects. NutriLeads aims to catalyze nutritional health innovation in the food industry by partnering with relevant companies to identify promising lead ingredients, develop sustainable and commercially viable production processes, and initiate scientific & clinical programs to substantiate the health effects of these ingredients. Together we will bring the benefits of the proprietary ingredients to patients and consumers.

Natreon

Venture Round in 2015
Natreon, Inc.is a company located in New Jersey with a state of the art R&D facility in Kolkata, India, and is focused on developing and marketing Ayurvedic products backed by extensive research, high degree of standardization, multiple clinical studies, safety studies, and intellectual property.

NovoPolymers

Venture Round in 2015
NovoPolymers NV develops encapsulant solutions for the photovoltaic market. It offers thermoplastic encapsulant sheets for crystalline silicon based photovoltaic modules; and hydrocarbon thermoplastic elastomer materials. The company was founded in 2008 and is based in Puurs, Belgium.

Interface Biologics, Inc.

Series B in 2015
Interface Biologics, Inc. (IBI) is a commercial stage company that develops transformative biomedical polymer technology to improve the safety and effectiveness of medical devices. Their patent-protected technologies include anti-thrombogenic additives for blood contacting medical devices and polymer enabled combination drug delivery devices. IBI has exclusive Endexo™ technology licensing agreements with AngioDynamics for vascular access catheters and with Fresenius Medical Care for chronic dialysis systems. AngioDynamics’ BioFlo PICCS, Ports and DuraMax Dialysis Catheter with IBI’s Endexo technology have received FDA clearance and are gaining commercial traction. IBI also has a joint venture commercial agreement with Qualimed to develop a drug-coated balloon based on IBI’s Kinesyx™ technology. The company was founded in 2001 and is headquartered in Toronto, Canada at the acclaimed MaRS Innovation Centre.

EyePromise

Venture Round in 2014
EyePromise manufactures and sells zeaxanthin dietary supplements for those at risk of age-related vision loss. It offers QuantifEYE program for assessing risk of developing age-related macular degeneration; EyePromise restore, a professional dietary supplement; and EyePromise ten-for those who prefer xeaxanthin supplement.

Verdezyne

Venture Round in 2014
Verdezyne was a privately-held company that employs its biological expertise and proprietary advanced computational algorithms to design and synthesize novel, high-diversity gene libraries for engineering proteins, metabolic pathways, and microorganisms. The company creates and harnesses this unique biological diversity to optimize commercial fermentation processes for the production of petrochemical replacements.

Isobionics

Venture Round in 2014
Isobionics B.V. develops, produces, and sells natural products for customers in flavor and fragrance market. It produces compounds, such as citrus oils that include lemon, orange, and grapefruit; compounds, including valencene and nootkatone, menthol, sandalwood oil, and patchouli oil; and other basic building blocks for the flavor and fragrance industry. The company was founded in 2008 and is based in Geleen, the Netherlands. As of September 26, 2019, Isobionics B.V. operates as a subsidiary of BASF SE.

ChromaDex

Post in 2013
ChromaDex Corporation is a nutraceutical company focused on promoting healthy aging through innovative ingredients and scientific research. It is best known for its flagship product, Nicotinamide riboside (NIAGEN), a form of vitamin B3 that helps enhance levels of nicotinamide adenine dinucleotide (NAD+), which naturally decline with age. The company also offers Immulina, a spirulina extract aimed at boosting immune function. ChromaDex operates through three primary segments: Consumer Products, Ingredients, and Analytical Reference Standards and Services, with the bulk of its revenue generated from the Consumer Products segment. The company is involved in developing and commercializing patented ingredient technologies for various markets, including dietary supplements, food, beverages, skincare, and pharmaceuticals. Alongside its product offerings, ChromaDex provides analytical testing and regulatory consulting services, reinforcing its commitment to quality and safety in its ingredient development. Headquartered in Los Angeles, California, ChromaDex continues to leverage its extensive intellectual property and scientific backing in the biosciences sector.

Arecor

Venture Round in 2013
Arecor is a leader in developing superior biopharmaceuticals through the application of its innovative formulation technology platform. Arecor is leveraging this platform to develop a portfolio of proprietary products enabling improved treatments for diabetes care via the innovative reformulation of approved proteins and peptides. In addition to its internal product portfolio, Arecor partners with leading pharmaceutical and biotech companies to deliver superior reformulations of their proprietary products, which would otherwise not be possible using conventional formulation science.

Segetis

Series C in 2012
Segetis, Inc. is a green chemistry company based in Golden Valley, Minnesota, that specializes in the development and commercialization of renewable polymers. Founded in 2006, Segetis utilizes a platform of binary monomers derived from non-food agricultural and forestry feedstocks to produce a range of materials. The company's innovative technology supports the creation of bio-based products, including bio-plastics, surfactants, plasticizers, adhesives, coalescent solvents, and other specialty chemicals. This approach not only enables the second wave of industrial bioproducts but also offers synergies for industries involved in the processing of starch, sugar crops, wood, cellulose, and vegetable oils. Through its focus on sustainable materials, Segetis is positioned to contribute significantly to the advancement of environmentally friendly chemical solutions.

Xolve

Funding Round in 2012
Xolve, Inc., a nanomaterials company, produces and supplies graphene that is used to improve the properties of various industrial plastics for use in automotive, aerospace, electronics, and other applications. It offers graphene-loaded polymer master batches, pristine graphene nanoplatelets, and exfoliated graphene. Xolve, Inc. was formerly known as Graphene Solutions, Inc. and changed its name to Xolve, Inc. in September 2010. The company was founded in 2008 and is based in Middleton, Wisconsin. As of March 31, 2016, Xolve, Inc. operates as a subsidiary of Reliance Industries Limited.

Regentis Biomaterials

Series C in 2012
Regentis Biomaterials is a privately held company focused on developing and commercializing proprietary hydrogels for tissue regeneration. The company’s core technology is a iodegradable hydrogel called Gelrin™. It is based on polyethylene glycol diacrylate and denatured fibrinogen originally developed at the Technion University by Dr. Dror Seliktar. The Gelrin hydrogel platform combines the stability and versatility of a synthetic material with the bio-functionality of a natural substance for a range of clinical applications and has undergone extensive preclinical and safety testing over the last few years. The company’s flagship product, GelrinC™,designed for the treatment of articular cartilage lesions, is currently in clinical trials.

Verdezyne

Venture Round in 2011
Verdezyne was a privately-held company that employs its biological expertise and proprietary advanced computational algorithms to design and synthesize novel, high-diversity gene libraries for engineering proteins, metabolic pathways, and microorganisms. The company creates and harnesses this unique biological diversity to optimize commercial fermentation processes for the production of petrochemical replacements.

CellMade

Funding Round in 2010
Cellmade SAS operates as a biopharmaceutical company. The company develops and supplies cell biology products such as blood cells, endothelial cells, epithelial cells, fibroblasts, hepactocytes, adipocytes, inflammatory and cardiovascular cells, pancreatic cells, skeleton muscle cells, and laboratory services, which includes biobank, cell based assays, cytometry, and mass spectrometry. Cellmade SAS was founded in 2007 and is based in Chappes, France with an additional location in Ruffieux, France.

Segetis

Series B in 2010
Segetis, Inc. is a green chemistry company based in Golden Valley, Minnesota, that specializes in the development and commercialization of renewable polymers. Founded in 2006, Segetis utilizes a platform of binary monomers derived from non-food agricultural and forestry feedstocks to produce a range of materials. The company's innovative technology supports the creation of bio-based products, including bio-plastics, surfactants, plasticizers, adhesives, coalescent solvents, and other specialty chemicals. This approach not only enables the second wave of industrial bioproducts but also offers synergies for industries involved in the processing of starch, sugar crops, wood, cellulose, and vegetable oils. Through its focus on sustainable materials, Segetis is positioned to contribute significantly to the advancement of environmentally friendly chemical solutions.

Novomer

Series B in 2009
Novomer is a new materials company pioneering a family of competitively priced high-performance green plastics, polymers and other chemicals. With proprietary catalytic technology and a world-class scientific team, Novomer's groundbreaking technology allows carbon dioxide and other renewable materials to be cost-effectively transformed into polymers, plastics and other chemicals for a wide variety of industrial markets. It was founded in 2004 and headquartered in Waltham, Massachusetts.

Viocare

Venture Round in 2009
Viocare, Inc. is a privately-held company bringing the benefits of cutting edge knowledge in the nutrition and behavior change sciences to the development of breakthrough web and mobile solutions that serve both researchers and the preventive care market.

Provexis

Post in 2008
Provexis is a company that develops, licenses, and markets functional foods, medical foods, and dietary supplements. Its flagship product, Fruitflow, is a tomato extract designed to reduce the risk of abnormal blood clotting, which is often linked to cardiovascular diseases like heart attacks and strokes. Fruitflow is available in syrup and powder forms and is incorporated into various food, beverage, and dietary supplement formats. The company also offers Fruitflow + Omega-3, a capsule supplement that promotes healthy blood flow and normal heart function. Provexis collaborates with By-Health Co., Ltd. to expand its reach and offers its products through retail outlets and online platforms. Founded in 1999, Provexis is headquartered in Reading, United Kingdom.

Ganeden, Inc.

Venture Round in 2007
Ganeden, Inc. is a manufacturer and supplier of probiotics and probiotic bacteria, focusing on innovative applications across various sectors. The company licenses its probiotic technology for use in functional food and beverages, dietary supplements, topical products, and animal health. Key offerings include GanedenBacillus coagulans for food and companion animal use, Bonicel for personal care products, and Staimune for immune health. Founded in 1997 and based in Mayfield Heights, Ohio, Ganeden has also developed a successful line of consumer products, including Digestive Advantage and Sustenex, which have collectively sold nearly 200 million doses through over 40,000 retail outlets. The company operates as a subsidiary of Kerry Group plc and maintains a strategic alliance with Sensus America.

Upfront Chromatography

Venture Round in 2007
Upfront Chromatography is a Denmark-based biotech company with significant expertise and regulatory experience in the development of customised industrial processes. Upfront develops and manufactures innovative products and technologies for extraction and recovery of biotherapeutics, functional biomolecules, macromolecular complexes, and even living cells, directly from bioreactors and industrial side-streams.
Food Quality Sensor International, Inc. operates as a sensor technology company. It develops and commercializes real-time and interactive food freshness measurement devices. The company provides SensorQ, which measures the level of freshness of meat or poultry within the package; and SensorfreshQ, a handheld electronic nose that detects meat and poultry spoilage. It serves food processing, grocery distribution, food service, regulatory, defense, and consumer retail markets. The company was incorporated in 2004 and is headquartered in Lexington, Massachusetts.

Harland Medical Systems

Private Equity Round in 2007
Harland Medical Systems, Inc. specializes in surface enhancement products for the healthcare industry, focusing on medical device coatings and related services. Founded in 2002 and headquartered in Eden Prairie, Minnesota, the company offers a range of solutions including antimicrobial coatings, coating materials for surface modification, and method development services for medical devices. Harland Medical Systems provides various coating systems for applying ultraviolet cured coatings, along with friction test equipment to assess the performance of lubricious coatings on devices such as catheters and guide wires. The company serves a diverse clientele across multiple clinical markets including neurology, urology, cardiology, wound care, and endoscopy, aiming to enhance patient outcomes and improve the economic value of healthcare products and procedures.

Micromuscle

Venture Round in 2006
Micromuscle AB was founded in 2000 to develop innovative biomedical products based on the company's proprietary electroactive polymer technology-MICROMUSCLE technology. Micromuscle's proprietary technology relates to electroactive polymers which are capable of expanding and contracting when subjected to an electric potential.

IntegraGen

Venture Round in 2006
IntegraGen is a French biotech company based on the Genopole life science park in Evry, near Paris. It leverages its unique intellectual property, research expertise and privileged access to sample libraries to develop molecular markers for central nervous system and metabolic diseases. IntegraGen notably uses its proprietary technology platforms to provide genomics services to the pharmaceutical industry, biotech firms and other research providers.

Sciona

Series C in 2006
Sciona provides gene-based personalized health and nutrition analysis and recommendations based on individual diet, lifestyle, and genetic profile. The company's Mycellf Program, which includes a diet and lifestyle questionnaire, makes recommendations for how individuals can make choices that benefit their long-term health. It also offers genetic testing products, which address personal wellness, fitness, and nutritional issues. The company was founded in 2000 and is headquartered in Aurora, Colorado.

ORYXE Energy International

Venture Round in 2005
ORYXE Energy International was founded in 2001 to solve the world’s dual need for dependable fuel supplies and a cleaner environment. By focusing on a specific challenge—cleaner-burning fuels—they have developed innovative additive technologies that improve fuel performance and make a meaningful reduction in toxic emissions from renewable and fossil fuels. Their products are proven, safe, cost-effective and available worldwide.

Sciona

Series B in 2004
Sciona provides gene-based personalized health and nutrition analysis and recommendations based on individual diet, lifestyle, and genetic profile. The company's Mycellf Program, which includes a diet and lifestyle questionnaire, makes recommendations for how individuals can make choices that benefit their long-term health. It also offers genetic testing products, which address personal wellness, fitness, and nutritional issues. The company was founded in 2000 and is headquartered in Aurora, Colorado.

Morphotek

Series C in 2004
Morphotek is one of the leading companies in the life science industry that develops novel classes of biological-based products to treat cancer, inflammation and infectious diseases. Since its founding in 2000, Morphotek has made extraordinary progress in discovering and developing monoclonal antibodies (mABs) to treat these diseases and continues to develop additional antibody products using its proprietary technologies. Post-graduate research executed by Morphotek’s President and CEO, Dr. Nicholas Nicolaides, during his studies at Johns Hopkins Medical School was the basis for the company’s inception. It was there that Dr. Nicolaides co-invented the company's legacy technology called morphogenics. Along with the honed applications for applying morphogenics for product development refined by the company’s other co-founders, Dr. Philip Sass and Dr. Luigi Grasso, morphogenics has taken Morphotek an incredible distance in the advancement of novel pharmaceutical products and targets.

Optiva

Series C in 2003
Optiva Inc. is a provider of cloud-native revenue management software tailored for communication service providers (CSP) across various global regions, including Europe, the Middle East, Africa, North America, Latin America, the Caribbean, Asia, and the Pacific Rim. The company's solutions facilitate real-time billing, charging, policy management, and enhanced user experiences. Notable products include the Optiva Charging Engine, which aids CSPs in monetizing next-generation services; the Optiva Policy Management solution, designed for data monetization in applications like video streaming and voice over LTE; and Optiva Wholesale Settlement, a cloud solution for accurate interconnect billing. Additionally, Optiva offers e-payment solutions and a comprehensive Business Support Systems Platform for converged billing. Founded in 1999 and headquartered in Mississauga, Canada, Optiva Inc. aims to support the growth and performance of its telecommunications customers through innovative software solutions.

Sciona

Series A in 2002
Sciona provides gene-based personalized health and nutrition analysis and recommendations based on individual diet, lifestyle, and genetic profile. The company's Mycellf Program, which includes a diet and lifestyle questionnaire, makes recommendations for how individuals can make choices that benefit their long-term health. It also offers genetic testing products, which address personal wellness, fitness, and nutritional issues. The company was founded in 2000 and is headquartered in Aurora, Colorado.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.